FLUMATINIB: 22 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
22
Total FAERS Reports
2 (9.1%)
Deaths Reported
4
Hospitalizations
22
As Primary/Secondary Suspect
First Report: 20210101 · Latest Report: 20250529
What Are the Most Common FLUMATINIB Side Effects?
#1 Most Reported
Myelosuppression
13 reports (59.1%)
#2 Most Reported
Gastrointestinal disorder
6 reports (27.3%)
#3 Most Reported
Pyrexia
4 reports (18.2%)
All FLUMATINIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 13 | 59.1% | 0 | 4 |
| Gastrointestinal disorder | 6 | 27.3% | 0 | 0 |
Who Reports FLUMATINIB Side Effects? Age & Gender Data
Gender: 38.1% female, 61.9% male. Average age: 53.4 years. Most reports from: CN. View detailed demographics →
Is FLUMATINIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 3 | 0 | 1 |
| 2022 | 1 | 0 | 0 |
| 2023 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 1 |
| 2025 | 1 | 0 | 0 |
What Is FLUMATINIB Used For?
| Indication | Reports |
|---|---|
| Acute lymphocytic leukaemia | 9 |
| Philadelphia positive acute lymphocytic leukaemia | 5 |
Official FDA Label for FLUMATINIB
Official prescribing information from the FDA-approved drug label.